Search | IOVS | ARVO Journals

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Potential role of mast cells in the pathology of L-ORD

Donita Garland; Anil Kumar Chekuri; Venkata R M Chavali; John Suk; Shyamanga Borooah; Radha Ayyagari

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4427. doi:

ARVO Annual Meeting Abstract June 2020

Comparison of retinal layer segmentation of non neovascular age-related macular degeneration patients with and without reticular pseudodrusen

Varsha Alex; Shyamanga Borooah; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1818. doi:

ARVO Annual Meeting Abstract June 2020

Single cell RNA sequencing of retinal immune cells identifies activation of resident retinal microglia associated with subretinal pseudodrusen-like deposits

Asha Kumari; Raul Ayala; Juan Carlos Zenteno; Sasik Roman; Radha Ayyagari; Shyamanga Borooah

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2748. doi:

Articles May 2020

Quantifying the Separation Between the Retinal Pigment Epithelium and Bruch's Membrane using Optical Coherence Tomography in Patients with Inherited Macular Degeneration

PDF

Kamron N. Khan; Shyamanga Borooah; Leonardo Lando; Kunny Dans; Omar A. Mahroo; Amit Meshi; Angelos Kalitzeos; Georgios Agorogiannis; Sasan Moghimi; William R. Freeman; Andrew R. Webster; Anthony T. Moore; Martin McKibbin; Michel Michaelides
TAGS: bruch's basal membrane, macular degeneration, optical coherence tomography, retinal pigment epithelium, spectral domain-optical coherence tomography, eye, drusen
Trans. Vis. Sci. Tech.. 2020; 9(6):26. doi: https://doi.org/10.1167/tvst.9.6.26

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Detection and validation of the involvement of novel mutations in MERTK in recessive retinal degeneration using WGS and hiPSC-RPEs.

Pooja Biswas; Shyamanga Borooah; Marina voronchikhina; Hiroko Matsui; Karl J Wahlin; Kelly Frazer; Radha Ayyagari

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1757. doi:

ARVO Annual Meeting Abstract July 2019

Regulation of HTRA1 activity by CTRP5 may underlie the pathology of Late Onset Retinal Degeneration (L-ORD).

Anil Kumar Chekuri; Katarzyna Zientara-Rytter; Shyamanga Borooah; Marina voronchikhina; Angel Soto-Hermida; Chloe Stanton; Hiroko Matsui; Matteo D'Antonio; Peter Shaw; David S Goodsell; Kelly Frazer; Caroline Hayward; Suresh Subramani; Radha Ayyagari

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4896. doi:

ARVO Annual Meeting Abstract July 2019

HTRA1 is increased in Bruch's membrane/choroid in a mouse model of L-ORD

Donita Garland; Anil Kumar Chekuri; Venkata Ramana Murthy Chavali; John Suk; Shyamanga Borooah; Radha Ayyagari

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4897. doi:

ARVO Annual Meeting Abstract July 2019

Characterizing two novel mouse models of Ctrp5/C1qtnf5 to understand disease mechanism in late-onset retinal degeneration.

Shyamanga Borooah; Marina voronchikhina; Anil Kumar Chekuri; Venkata Ramana Murthy Chavali; John Suk; Akhila Alapati; Dirk-Uwe G Bartsch; Naheed W Khan; Monica M Jablonski; Radha Ayyagari

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5030. doi:

ARVO Annual Meeting Abstract July 2019

10-year Mortality and Clinical Outcomes in Patients with Neovascular Age-related Macular Degeneration Treated with Intravitreal Anti-VEGF Injections.

Su Ling Young; Martin Anderson; Shyamanga Borooah; Ana Maria Ambrecht; Peter D Cackett

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):86. doi:

ARVO Annual Meeting Abstract July 2018

Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab.

Peter Cackett; Flora Elwes; Peter Aspinall; Peng Yong Sim; Cheng Yi Loo; Bal Dhillon; Ana Maria Armbrecht; Ali Al-Ani; Shyamanga Borooah

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2383. doi:

ARVO Annual Meeting Abstract July 2018

A homozygous mutation in the novel gene ARFGAP2 is associated with non-syndromic recessive inherited retinal degeneration (IRD).

Pooja Biswas; Anil Kumar Chekuri; Jason Ear; Shyamanga Borooah; Hiroko Matsui; Matteo D'Antonio; Kelly A. Frazer; Sindhura Devalaraja; Shahid Yar Khan; Muhammad Asif Naeem; Sheikh Riazuddin; Javed Akram; J. Fielding Hejtmancik; Pradipta Ghosh; S Amer Riazuddin; Radha Ayyagari

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5383. doi:

ARVO Annual Meeting Abstract July 2018

Acute symptomatic posterior vitreous detachments do not adversely affect contrast sensitivity

Kunny C Dans; Daniel Chao; Amit Meshi; Tiezhu Lin; Manuel Amador; Shyamanga Borooah; Kevin Chen; Maria Laura Gomez; Dirk-Uwe G Bartsch; Eric Nudleman; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1846. doi:

ARVO Annual Meeting Abstract June 2017

Identifying causes for delays from symptom onset to treatment in patients with wet age-related macular degeneration (AMD) in south-east Scotland

Peng Yong Sim; Sonul Gajree; Baljean Dhillon; Shyamanga Borooah

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1525. doi:

ARVO Annual Meeting Abstract September 2016

New Public Retinal Image Database for Tortuosity Evaluation

Jeffrey C Wigdahl; Roberto Annunziata; Laura Hughes; Shyamanga Borooah; Alfredo Ruggeri; Emanuele Trucco

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3399. doi:

ARVO Annual Meeting Abstract June 2015

Multimodal imaging highlights novel phenotypic changes in late-onset retinal macular degeneration prior to loss of visual acuity

Shyamanga Borooah; Vasileios Papastavrou; James R Cameron; Ashraf Khan; Andrew Browning; Baljean Dhillon

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2813. doi:

ARVO Annual Meeting Abstract June 2015

Intravitreal ranibizumab treatment of wet macular degeneration followed by a switch of anti-VEGF to aflibercept

Flora Elwes; Shyamanga Borooah; Peter Cackett

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4587. doi:

ARVO Annual Meeting Abstract June 2015

Clinical utility of retinal and choroidal OCT in the assessment of chronic kidney disease

James R Cameron; Shyamanga Borooah; Craig Balmforth; Titia Ruijs; Tom MacGillivray; Baljean Dhillon; David Webb; Neeraj Dhaun

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5907. doi:

ARVO Annual Meeting Abstract June 2013

Late-Onset Retinal Macular Degeneration: refining the phenotype

Shyamanga Borooah; Vasileios Papastavrou; Andrew Browning; Baljean Dhillon

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1368. doi:

ARVO Annual Meeting Abstract June 2013

Intravitreal ranibizumab treatment of wet macular degeneration in SE Scotland - effect on blindness rates and 5 year follow up data

Peter Cackett; Shyamanga Borooah; Mike Gavin; Dilys Oladiwura; V.Swetha Jeganathan; Scotland AMD study group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):372. doi:

ARVO Annual Meeting Abstract March 2012

One Year Visual Outcomes For Macula-off Rhegmatogenous Retinal Detachment

Danny Mitry; M.A. Awan; Shyamanga Borooah; Andreas Syrogiannis; Charles Lim-Fat; Harry Campbell; Brian W. Fleck; David Charteris; David Yorston; Jaswinder Singh

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):989. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Potential role of mast cells in the pathology of L-ORD

Comparison of retinal layer segmentation of non neovascular age-related macular degeneration patients with and without reticular pseudodrusen

Single cell RNA sequencing of retinal immune cells identifies activation of resident retinal microglia associated with subretinal pseudodrusen-like deposits

Quantifying the Separation Between the Retinal Pigment Epithelium and Bruch's Membrane using Optical Coherence Tomography in Patients with Inherited Macular Degeneration

Detection and validation of the involvement of novel mutations in MERTK in recessive retinal degeneration using WGS and hiPSC-RPEs.

Regulation of HTRA1 activity by CTRP5 may underlie the pathology of Late Onset Retinal Degeneration (L-ORD).

HTRA1 is increased in Bruch's membrane/choroid in a mouse model of L-ORD

Characterizing two novel mouse models of Ctrp5/C1qtnf5 to understand disease mechanism in late-onset retinal degeneration.

10-year Mortality and Clinical Outcomes in Patients with Neovascular Age-related Macular Degeneration Treated with Intravitreal Anti-VEGF Injections.

Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab.

A homozygous mutation in the novel gene ARFGAP2 is associated with non-syndromic recessive inherited retinal degeneration (IRD).

Acute symptomatic posterior vitreous detachments do not adversely affect contrast sensitivity

Identifying causes for delays from symptom onset to treatment in patients with wet age-related macular degeneration (AMD) in south-east Scotland

New Public Retinal Image Database for Tortuosity Evaluation

Multimodal imaging highlights novel phenotypic changes in late-onset retinal macular degeneration prior to loss of visual acuity

Intravitreal ranibizumab treatment of wet macular degeneration followed by a switch of anti-VEGF to aflibercept

Clinical utility of retinal and choroidal OCT in the assessment of chronic kidney disease

Late-Onset Retinal Macular Degeneration: refining the phenotype

Intravitreal ranibizumab treatment of wet macular degeneration in SE Scotland - effect on blindness rates and 5 year follow up data

One Year Visual Outcomes For Macula-off Rhegmatogenous Retinal Detachment

To View More...

You must be signed into an individual account to use this feature.